• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

USX Stablecoin Faces Liquidity Crisis but Recovers

chest

USX stablecoin on Solana faced a liquidity crisis, dropping to 0.1, but recovered to 0.94 after emergency funds were injected by the Solstice team.

user avatarSatoshi Nakamura

Yen Weakness Highlights Policy Challenges in Japan

chest

Yen weakness persists despite rate hikes by the Bank of Japan, highlighting challenges in managing monetary policy and exchange rate stability.

user avatarRajesh Kumar

Polymarket Users Anticipate No Changes to Interest Rates

chest

Polymarket users predict an 88% chance of no changes to interest rates at the upcoming FOMC meeting on January 27-28, 2026.

user avatarJesper Sørensen

Pumpfun Emerges as a Game-Changer in Solana's DeFi Landscape

chest

Pumpfun is revolutionizing meme coin creation on the Solana blockchain, making it accessible to everyone.

user avatarFilippo Romano

Solana's DeFi Ecosystem Experiences Unprecedented Growth

chest

The total value locked in Solana's DeFi ecosystem has increased dramatically, benefiting platforms like Pumpfun.

user avatarLucas Weissmann

Rocket's Continuous Redistribution Model Challenges Traditional Prediction Markets

chest

Rocket's innovative approach replaces traditional prediction market structures with continuous redistribution of capital based on real-time accuracy.

user avatarKaterina Papadopoulou

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.